FY results are in line with expectations, highlighting the continued expansion and integration of Abzena’s Services and GMP Manufacturing offering across the company’s 3 sites in the US and UK. Following the £23.9m (net) fundraise in April the company is well funded to pursue its Investment and Growth plan, targeting a 40% 3-year CAGR in revenue and an accelerated transition to profitability. We note that contracted revenue for the current year already exceeds 50% of FY2017 revenue, supported by ....
13 Jun 2017
N+1 Singer - Abzena - FY results in line; fully funded for investment and growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Abzena - FY results in line; fully funded for investment and growth
Abzena (ABZA:LON) | 0 0 (-0.9%) | Mkt Cap: 54.0m
- Published:
13 Jun 2017 -
Author:
Dr Jens Lindqvist -
Pages:
3
FY results are in line with expectations, highlighting the continued expansion and integration of Abzena’s Services and GMP Manufacturing offering across the company’s 3 sites in the US and UK. Following the £23.9m (net) fundraise in April the company is well funded to pursue its Investment and Growth plan, targeting a 40% 3-year CAGR in revenue and an accelerated transition to profitability. We note that contracted revenue for the current year already exceeds 50% of FY2017 revenue, supported by ....